Zealand Pharma A/S
OTC:ZLDPF

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
OTC:ZLDPF
Watchlist
Price: 70.3455 USD -0.18% Market Closed
Market Cap: 5B USD

Wall Street
Price Targets

ZLDPF Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZLDPF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZLDPF is 144.0745 USD with a low forecast of 76.0968 USD and a high forecast of 182.6885 USD.

Lowest
Price Target
76.0968 USD
8% Upside
Average
Price Target
144.0745 USD
105% Upside
Highest
Price Target
182.6885 USD
160% Upside
Zealand Pharma A/S Competitors:
Price Targets
IVA
Inventiva SA
198% Upside
ADAG
Adagene Inc
398% Upside
CUV
Clinuvel Pharmaceuticals Ltd
151% Upside
VCYT
Veracyte Inc
60% Upside
4599
StemRIM Inc
123% Upside
4593
Healios KK
9% Downside
TSHA
Taysha Gene Therapies Inc
162% Upside
TRDA
Entrada Therapeutics Inc
193% Upside

Revenue
Forecast

Revenue Estimate
Zealand Pharma A/S

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is -15%. The projected CAGR for the next 3 years is 205%.

-15%
Past Growth
205%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-33%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZLDPF's stock price target?
Price Target
144.0745 USD

According to Wall Street analysts, the average 1-year price target for ZLDPF is 144.0745 USD with a low forecast of 76.0968 USD and a high forecast of 182.6885 USD.

What is Zealand Pharma A/S's Revenue forecast?
Projected CAGR
205%

For the last 8 years the compound annual growth rate for Zealand Pharma A/S's revenue is -15%. The projected CAGR for the next 3 years is 205%.

Back to Top